D-1028-2018 Class II Terminated

Recalled by Bryant Ranch Prepack Inc. — Burbank, CA

FDA drug recall D-1028-2018 was initiated by Bryant Ranch Prepack Inc. on Jul 27, 2018 and is designated Class II. Reason for recall: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product. The recall status is terminated (terminated Apr 22, 2021). Affected quantity: 990 tablets.

Recall details

Product Type
Drugs
Report Date
Aug 8, 2018
Initiation Date
Jul 27, 2018
Termination Date
Apr 22, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
990 tablets

Product description

Valsartan 320 mg tablets, 30-count bottles ( NDC 63629-6905-1), 90-count bottles (NDC 63629-6905-2), 28-count bottles (NDC 6362-96905-3), Rx Only, Packaged by Bryant Ranch, Burbank, CA 91504.

Reason for recall

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Distribution pattern

Product was distributed in HI, IN, and FL.

Code information

Lot # 114319; Exp. 10/18 Lot # 109004; Exp. 12/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1028-2018
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1028-2018. Report a data issue: hello@regdatalab.com.